The import of penicillins or streptomycins in dosage forms to China is forecasted to increase steadily from 2024 to 2028. Starting at 2.5905 million kilograms in 2024, the volume rises incrementally each year, reaching 2.9228 million kilograms by 2028. This represents a compound annual growth rate over the period, indicating a consistent upward trend. In 2023, the import volume was lower than the starting point of the forecast in 2024, reflecting an anticipated rise in demand.

Future trends to watch for include:

Increasing healthcare needs in China, potentially driving greater imports.
Policy changes in healthcare or trade that could influence volumes.
Developments in domestic pharmaceutical production, which may affect import levels.
Global market dynamics and supply chain factors influencing availability and pricing.